Amy Harper
Neurology with Special Qualifications in Child Neurology · Richmond, VANPI 1659393817
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Sarepta Therapeutics, Inc. accounts for 87.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $15,061 and has fallen 89.4% since, to $1,590 in 2025.
Across 43 payments — averaging $1070.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$40K
- Catalyst Pharmaceuticals, Inc.$2K
- ITF Therapeutics LLC$2K
- NS Pharma, Inc.$1K
- Genentech USA, Inc.$144
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$43
- plus $61 from 3 others
Across 219 payments — averaging $5222.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- NS Pharma, Inc.$741K
- Astellas Pharma Inc$226K
- Novartis$87K
- Teva Pharmaceuticals USA, Inc.$62K
- Sarepta Therapeutics, Inc.$19K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$9K
What the payments were for
- Consulting fees$20,41544%
- Speaking & faculty fees$23,51351%
- Travel & lodging$1,4443%
- Food & beverage$6191%
- Education$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 28 | $40,368 |
| Catalyst Pharmaceuticals, Inc. | 1 | $2,400 |
| ITF Therapeutics LLC | 1 | $1,590 |
| NS Pharma, Inc. | 2 | $1,410 |
| Genentech USA, Inc. | 1 | $144 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 2 | $43 |
| Travere Therapeutics, Inc. | 6 | $26 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,017 in reported general payments places this provider in the 85th percentile of 23 neurology with special qualifications in child neurology providers in Virginia.
See all neurology with special qualifications in child neurology providers in Virginia →
Other neurology with special qualifications in child neurology in Richmond
- Mathula ThangarajhRichmond$47K
- Lawrence MortonRichmond$17K
- Alison AlfordRichmond$13K
- Donald TaylorRichmond$256
- Monica IslamRichmond$236
- Miranda LeeRichmond$85
- Crystal ProudNorfolk$1M
- Michael StruncNorfolk$639K
- Nassim ZecavatiFredericksburg$5K
- Ryan WilliamsNorfolk$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.